Invest Daily Pro
  • Economy
  • Investing
No Result
View All Result
  • Economy
  • Investing
No Result
View All Result
Invest Daily Pro
No Result
View All Result
Home Economy

Glass Pharms Welcomes Adam George as New Chairman

by
January 8, 2025
in Economy, Investing
0
Glass Pharms Welcomes Adam George as New Chairman
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

Glass Pharms, a leading UK-based medical cannabis cultivation company, is pleased to announce the appointment of Adam George as Chairman, effective as of December 1st, 2024.

Adam brings with him over 13 years of experience in the pharmaceutical cannabis industry, having previously held positions such as CFO and UK managing director at GW Pharmaceuticals. His extensive knowledge and expertise in this field will be instrumental in supporting Glass Pharms’ mission to provide high quality pharmaceutical cannabis products to patients in the UK.

James Duckenfield, Glass Pharms’ chief executive, expressed his enthusiasm for the new addition to the board, stating, “We are delighted that Adam has joined the team. His experience and expertise will be invaluable as we continue to strive towards our goal of providing reliable and high-quality cannabis-based medicines to patients in the UK.”

Adam George left GW Pharmaceuticals, now known as Jazz Pharmaceuticals, in 2020 and has since been involved in various businesses focused on developing medicines derived from natural sources, including plants and fungi.

In his statement, Adam said, “I am thrilled to be joining Glass Pharms at such an exciting time. With a world-class cultivation facility and a dedicated team, the company is well-positioned to meet the increasing demand for high-quality, UK-produced cannabis-based medicines.”

Glass Pharms is a licensed cultivator of cannabis, exclusively for the medical supply chain, in the UK. The company was founded with the aim of providing patients with a dependable supply of high-quality, UK-produced cannabis-based medicines at an affordable price. With a talented growing team and a unique patent-pending continuous cultivation system, Glass Pharms is able to produce a consistent supply of pharmaceutical-grade cannabis. This innovative system uses automation and climate chambers to simulate a full growing year in just 12 weeks, using only 40% of the power required by traditional indoor growing facilities. Additionally, the company is committed to using off-grid green energy to power its operations.

For more information about Glass Pharms, please visit their website at https://glasspharms.com/. For media inquiries, please contact Mark Heley at info@glasspharms.com.

This news release was distributed by https://pressat.co.uk/.

ShareTweetPin

Related Posts

Blue Lagoon’s Dome Mountain Joins BC’s Select List of Permitted Projects
Investing

Blue Lagoon’s Dome Mountain Joins BC’s Select List of Permitted Projects

June 2, 2025
Harmony Gold to Acquire MAC Copper in US$1.03 Billion Deal
Investing

Harmony Gold to Acquire MAC Copper in US$1.03 Billion Deal

June 2, 2025
Editor’s Picks: Gold Faces Bumpy Week on Trade Tensions, Platinum Stages Breakout
Investing

Editor’s Picks: Gold Faces Bumpy Week on Trade Tensions, Platinum Stages Breakout

June 1, 2025
Top 5 Canadian Mining Stocks This Week: Adyton Sparkles with 97 Percent Gain
Investing

Top 5 Canadian Mining Stocks This Week: Adyton Sparkles with 97 Percent Gain

May 31, 2025
NVIDIA Rallies After Strong Q1, AI Demand Outshines China Export Hit
Investing

NVIDIA Rallies After Strong Q1, AI Demand Outshines China Export Hit

May 31, 2025
CDX May Investor Presentation
Investing

CDX May Investor Presentation

May 30, 2025
Next Post
British Study Shows Call for Clearer, More Transparent and Standardized Food Labels

British Study Shows Call for Clearer, More Transparent and Standardized Food Labels

Recommended

Personalized Options Trading Strategies: Discover High-Yield Covered Calls and Spreads with the OptionsPlay Add-On

Personalized Options Trading Strategies: Discover High-Yield Covered Calls and Spreads with the OptionsPlay Add-On

April 30, 2025
Baguio taps students for smart city project

Baguio taps students for smart city project

September 24, 2024
Three Behavioral Biases Impacting Your Portfolio Right Now

Three Behavioral Biases Impacting Your Portfolio Right Now

February 5, 2025
Improving the patient journey in the Philippines

Improving the patient journey in the Philippines

September 15, 2024
The Best Five Sectors, #18

The Best Five Sectors, #18

May 6, 2025
Autohub scoots into Segway, too

Autohub scoots into Segway, too

September 29, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 InvestDailyPro. All Rights Reserved.

    Disclaimer: InvestDailyPro.com, its managers, its employees, and assigns (collectively InvestDailyPro ) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice.
    The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    No Result
    View All Result
    • About us
    • Contact us
    • Home
    • Privacy Policy
    • Suspicious engagement
    • Terms & Conditions
    • Terms & Conditions
    • Thank you

    Copyright © 2024 investdailypro.com | All Rights Reserved